Not all people with CLL need therapy. Despite all current advancements, the iwCLL even now recommends watchful observation for clients with asymptomatic condition.86 This suggestion is based on at the least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Both equally trials concluded https://rogerm419fnw6.bloggactif.com/profile